GR activity was reduced by exercise in a time-dependent manner, while no changes were observed in GPx and GST activities during time
This pharmaceutical-grade diluent is designed solely for parenteral use to dilute or dissolve compatible drugs
Glucagon-like peptide-1 (GLP-1) agonists are medications used to help individuals with Type 2 Diabetes (T2DM) and obesity
All three lots of plasma showed acceptable results that were less than 11% different from the expected values for both intra- and interday repeatability studies as demonstrated in Table IV and Table V below
Common adverse reactions in TRESIBA treated pediatric patients with type 1 diabetes mellitus were similar to the adverse reactions listed in Table 1
Wang T, Reingruber J, Woodruff ML, Majumder A, Camarena A, Artemyev NO, Fain GL, Chen J